These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35411262)

  • 21. New concepts in embolotherapy of HCC.
    Pesapane F; Nezami N; Patella F; Geschwind JF
    Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization].
    Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transarterial ablation of hepatocellular carcinoma. Status and developments].
    Radeleff BA; Stampfl U; Sommer CM; Bellemann N; Hoffmann K; Ganten T; Ehehalt R; Kauczor HU
    Radiologe; 2012 Jan; 52(1):44-55. PubMed ID: 22249701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial Radioembolization (TARE) with
    Patel A; Subbanna I; Bhargavi V; Swamy S; Kallur KG; Patil S
    South Asian J Cancer; 2021 Apr; 10(2):81-86. PubMed ID: 34568220
    [No Abstract]   [Full Text] [Related]  

  • 26. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage.
    Cappelli A; Sangro P; Mosconi C; Deppe I; Terzi E; Bilbao JI; Rodriguez-Fraile M; De Benedittis C; Ricke J; Golfieri R; Sangro B
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):661-668. PubMed ID: 30209522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unresectable Hepatocellular Carcinoma: Radioembolization Versus Chemoembolization: A Systematic Review and Meta-analysis.
    Lobo L; Yakoub D; Picado O; Ripat C; Pendola F; Sharma R; ElTawil R; Kwon D; Venkat S; Portelance L; Yechieli R
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1580-1588. PubMed ID: 27586657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein.
    Yu SJ; Kim YJ
    World J Hepatol; 2015 Jun; 7(11):1553-61. PubMed ID: 26085914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques.
    Imai N; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Goto H
    World J Hepatol; 2014 Dec; 6(12):844-50. PubMed ID: 25544871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
    Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
    Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation.
    Zori AG; Ismael MN; Limaye AR; Firpi R; Morelli G; Soldevila-Pico C; Suman A; Vogel JD; Lazarowicz M; Geller BS; Toskich B; Gonzalo DH; Johnson MW; Cabrera R
    Am J Clin Oncol; 2020 May; 43(5):325-333. PubMed ID: 32079854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioembolization for the treatment of hepatocellular carcinoma.
    Kim HC
    Clin Mol Hepatol; 2017 Jun; 23(2):109-114. PubMed ID: 28494530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments.
    Cappelli A; Pettinato C; Golfieri R
    J Hepatocell Carcinoma; 2014; 1():163-82. PubMed ID: 27508185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of transarterial radioembolization.
    Mahnken AH
    World J Radiol; 2016 May; 8(5):449-59. PubMed ID: 27247711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage locoregional therapies for recurrent hepatocellular carcinoma.
    Criss CR; Makary MS
    World J Gastroenterol; 2023 Jan; 29(3):413-424. PubMed ID: 36688022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.
    Gutierrez JA; Gish RG
    Transl Cancer Res; 2013 Dec; 2(6):460-471. PubMed ID: 26504748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
    Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
    J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    Young S; Golzarian J
    AJR Am J Roentgenol; 2020 Jul; 215(1):223-234. PubMed ID: 32255691
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.